These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 8981830)

  • 41. Suplatast tosilate protects the lung against hyperoxic lung injury by scavenging hydroxyl radicals.
    Fukuhara K; Nakashima T; Abe M; Masuda T; Hamada H; Iwamoto H; Fujitaka K; Kohno N; Hattori N
    Free Radic Biol Med; 2017 May; 106():1-9. PubMed ID: 28188922
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Suplatast tosilate, a new type of antiallergic agent, prevents the expression of airway hyperresponsiveness in guinea pigs.
    Taniguchi H; Togawa M; Ohwada K; Kiniwa M; Matsuura N; Nagai H; Koda A
    Eur J Pharmacol; 1996 Dec; 318(2-3):447-54. PubMed ID: 9016937
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Suplatast tosilate alleviates nasal symptoms through the suppression of nuclear factor of activated T-cells-mediated IL-9 gene expression in toluene-2,4-diisocyanate-sensitized rats.
    Mizuguchi H; Orimoto N; Kadota T; Kominami T; Das AK; Sawada A; Tamada M; Miyagi K; Adachi T; Matsumoto M; Kosaka T; Kitamura Y; Takeda N; Fukui H
    J Pharmacol Sci; 2016 Mar; 130(3):151-8. PubMed ID: 26874672
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of an orally active Th2 cytokine inhibitor, suplatast on "atopic cough" tosilate.
    Ishiura Y; Fujimura M; Yamamoto H; Nobata K; Ishiguro T; Ogawa H; Myou S
    Arzneimittelforschung; 2008; 58(6):297-302. PubMed ID: 18677972
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Treatment of non-episodic angioedema associated with eosinophilia with suplatast tosilate, an anti-allergic selective Th2 cytokine inhibitor.
    Hashizume H; Umayahara T
    Eur J Dermatol; 2014; 24(2):250-2. PubMed ID: 24723649
    [No Abstract]   [Full Text] [Related]  

  • 46. CD28 and secretory immunoglobulin A-dependent activation of eosinophils: inhibition of mediator release by the anti-allergic drug, suplatast tosilate.
    Woerly G; Decot V; Loiseau S; Loyens M; Chihara J; Ono N; Capron M
    Clin Exp Allergy; 2004 Sep; 34(9):1379-87. PubMed ID: 15347370
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Separation of non-racemic mixtures of enantiomers: an essential part of optical resolution.
    Faigl F; Fogassy E; Nógrádi M; Pálovics E; Schindler J
    Org Biomol Chem; 2010 Mar; 8(5):947-59. PubMed ID: 20165781
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Successful treatment of eosinophilic gastroenteritis with suplatast tosilate.
    Shirai T; Hashimoto D; Suzuki K; Osawa S; Aonahata M; Chida K; Nakamura H
    J Allergy Clin Immunol; 2001 May; 107(5):924-5. PubMed ID: 11344364
    [No Abstract]   [Full Text] [Related]  

  • 49. Kimura's disease treated with suplatast tosilate and loratadine.
    Ueda T; Arai S; Amoh Y; Katsuoka K
    Eur J Dermatol; 2011; 21(6):1020-1. PubMed ID: 21914581
    [No Abstract]   [Full Text] [Related]  

  • 50. Early intervention with suplatast tosilate for prophylaxis of pediatric atopic asthma: a pilot study.
    Yoshihara S; Ono M; Yamada Y; Fukuda H; Abe T; Arisaka O
    Pediatr Allergy Immunol; 2009 Aug; 20(5):486-92. PubMed ID: 19210644
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effect of melting point of chiral terpenes on human stratum corneum uptake.
    Mackay KM; Williams AC; Barry BW
    Int J Pharm; 2001 Oct; 228(1-2):89-97. PubMed ID: 11576771
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pemphigoid nodularis associated with psoriatic erythroderma: successful treatment with suplatast tosilate.
    Teraki Y; Fukuda T
    Br J Dermatol; 2008 Feb; 158(2):424-6. PubMed ID: 18047503
    [No Abstract]   [Full Text] [Related]  

  • 53. Suplatast tosilate dimethylsulfonium treatment for steroid-dependent nephrotic syndrome.
    Ohtomo Y; Fujinaga S; Hattori M
    Pediatr Int; 2005 Apr; 47(2):230-1. PubMed ID: 15771702
    [No Abstract]   [Full Text] [Related]  

  • 54. Th2 cytokine inhibitor suplatast tosilate inhibits antigen-induced mucus hypersecretion in the nasal epithelium of sensitized rats.
    Shimizu S; Hattori R; Majima Y; Shimizu T
    Ann Otol Rhinol Laryngol; 2009 Jan; 118(1):67-72. PubMed ID: 19244966
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Thermal, Spectroscopic, and Crystallographic Analysis of Mannose-Derived Linear Polyols.
    Mattsson I; Lahtinen M; Peuronen A; Sau A; Gunell A; Saloranta-Simell T; Leino R
    Cryst Growth Des; 2018 May; 18(5):3151-3160. PubMed ID: 30258305
    [TBL] [Abstract][Full Text] [Related]  

  • 56. A case of recurrent cutaneous eosinophilic vasculitis: successful adjuvant therapy with suplatast tosilate.
    Sakuma-Oyama Y; Nishibu A; Oyama N; Saito M; Nakamura K; Kaneko F
    Br J Dermatol; 2003 Oct; 149(4):901-3. PubMed ID: 14616398
    [No Abstract]   [Full Text] [Related]  

  • 57. Polymorphism of racemic felodipine and the unusual series of solid solutions in the binary system of its enantiomers.
    Rollinger JM; Burger A
    J Pharm Sci; 2001 Jul; 90(7):949-59. PubMed ID: 11458342
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Inhibitory effect of azelastine hydrochloride and suplatast tosilate on airway responses in sensitized rats following exposure to antigen.
    Hanashiro K; Tamaki N; Koga T; Nakamura M; Kinjoh K; Kosugi T
    Int J Tissue React; 1997; 19(3-4):163-9. PubMed ID: 9506318
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Characterization of racemic species of chiral drugs using thermal analysis, thermodynamic calculation, and structural studies.
    Li ZJ; Zell MT; Munson EJ; Grant DJ
    J Pharm Sci; 1999 Mar; 88(3):337-46. PubMed ID: 10052993
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Successful treatment of pediatric hypereosinophilic syndrome with suplatast tosilate.
    Yamada Y; Yoshihara S; Arisaka O
    Ann Allergy Asthma Immunol; 2007 Oct; 99(4):380-1. PubMed ID: 17941289
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.